Released Mar 10, 2016, after the close
10-K filed Mar 10, 2016, 70 days after period end · 0001390478-16-000088
Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$19.68M-$19.68M derivedN/M vs Q4 2014N/M vs Q1 2015
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$7,590,000N/M
Operating Cash Flowderived-$15,284,000N/M
Free Cash Flowderived-$15,356,000N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | — | $3.20M | $1.44M | $1.44M |
| Net Income | -$19.68M | -$7.96M | -$5.52M | -$19.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR